These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19110234)

  • 1. Azacitidine enhances sensitivity of platinum-resistant ovarian cancer cells to carboplatin through induction of apoptosis.
    Li Y; Hu W; Shen DY; Kavanagh JJ; Fu S
    Am J Obstet Gynecol; 2009 Feb; 200(2):177.e1-9. PubMed ID: 19110234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.
    Witham J; Valenti MR; De-Haven-Brandon AK; Vidot S; Eccles SA; Kaye SB; Richardson A
    Clin Cancer Res; 2007 Dec; 13(23):7191-8. PubMed ID: 18056200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAU regulates carboplatin resistance in ovarian cancer.
    Moss EL; Mourtada-Maarabouni M; Pickard MR; Redman CW; Williams GT
    Genes Chromosomes Cancer; 2010 Jan; 49(1):70-7. PubMed ID: 19830698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis-based evaluation of chemosensitivity in ovarian cancer patients.
    Flick MB; O'Malley D; Rutherford T; Rodov S; Kamsteeg M; Hao XY; Schwartz P; Kacinski BM; Mor G
    J Soc Gynecol Investig; 2004 May; 11(4):252-9. PubMed ID: 15120700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.
    Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
    Biochem Pharmacol; 2009 Apr; 77(8):1328-36. PubMed ID: 19426671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100P sensitizes ovarian cancer cells to carboplatin and paclitaxel in vitro.
    Wang Q; He Z; Gao J; Hu S; Huang M; Liu M; Zheng J; Tang H
    Cancer Lett; 2008 Dec; 272(2):277-84. PubMed ID: 18762368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on antitumor drug-induced apoptosis in human cancer cells by terminal deoxynucleotidyl transferase assay].
    Tong T; Sun H; Liu L
    Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):111-4. PubMed ID: 10743073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone) induces apoptosis in ovarian cancer cells.
    Alvero AB; Chen W; Sartorelli AC; Schwartz P; Rutherford T; Mor G
    J Soc Gynecol Investig; 2006 Feb; 13(2):145-52. PubMed ID: 16443509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol.
    Thomadaki H; Scorilas A
    Biol Chem; 2008 Nov; 389(11):1427-34. PubMed ID: 18783338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitous induction of resistance to platinum drugs in human ovarian, cervical, germ-cell and lung carcinoma tumor cells overexpressing isoforms 1 and 2 of dihydrodiol dehydrogenase.
    Deng HB; Adikari M; Parekh HK; Simpkins H
    Cancer Chemother Pharmacol; 2004 Oct; 54(4):301-7. PubMed ID: 15138708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro.
    Li J; Liu P; Mao H; Wanga A; Zhang X
    Oncol Rep; 2009 Jun; 21(6):1605-10. PubMed ID: 19424643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of mitochondria in cisplatin-resistant human ovarian carcinoma cells.
    Hirama M; Isonishi S; Yasuda M; Ishikawa H
    Oncol Rep; 2006 Nov; 16(5):997-1002. PubMed ID: 17016583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of combined treatment with progesterone and tamoxifen on the growth and apoptosis of human ovarian cancer cells.
    Lee JY; Shin JY; Kim HS; Heo JI; Kho YJ; Kang HJ; Park SH; Lee JY
    Oncol Rep; 2012 Jan; 27(1):87-93. PubMed ID: 21922150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis: a differential expression and functional analysis.
    Chan QK; Ngan HY; Ip PP; Liu VW; Xue WC; Cheung AN
    Carcinogenesis; 2009 Jan; 30(1):114-21. PubMed ID: 18796737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
    Zhang Y; Wang J; Xiang D; Wang D; Xin X
    Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-resistance of platinum derivatives in H-1R, a cisplatin-resistant cell line.
    Negoro K; Yamano Y; Nakashima D; Saito K; Nakatani K; Shiiba M; Bukawa H; Yokoe H; Uzawa K; Wada T; Tanzawa H; Fujita S
    Oncol Rep; 2009 Feb; 21(2):443-9. PubMed ID: 19148521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution genomic profiling of carboplatin resistance in early-stage epithelial ovarian carcinoma.
    Osterberg L; Levan K; Partheen K; Staaf J; Sundfeldt K; Horvath G
    Cytogenet Genome Res; 2009; 125(1):8-18. PubMed ID: 19617691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of the cytotoxicity activity of paclitaxel by orobol and platelet derived growth factor in human ovarian carcinoma cells.
    Isonishi S; Saitou M; Saitou M; Yasuda M; Tanaka T
    Oncol Rep; 2007 Jul; 18(1):195-201. PubMed ID: 17549368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of DOK2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis.
    Lum E; Vigliotti M; Banerjee N; Cutter N; Wrzeszczynski KO; Khan S; Kamalakaran S; Levine DA; Dimitrova N; Lucito R
    Gynecol Oncol; 2013 Aug; 130(2):369-76. PubMed ID: 23684582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA.
    Su D; Deng H; Zhao X; Zhang X; Chen L; Chen X; Li Z; Bai Y; Wang Y; Zhong Q; Yi T; Qian Z; Wei Y
    Cytotherapy; 2009; 11(5):642-52. PubMed ID: 19593703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.